Cryo-Save Group: Dividend proposal increase of 17%

Cryo-Save Group: Dividend proposal increase of 17%

ID: 51300

(Thomson Reuters ONE) -


Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's
leading adult stem cell storage bank, announces that the Board plans to propose
a dividend of ?0.07 per share for the year ended 31 December 2010 (2009: ?0.06)
, a 17% increase on last year.

For the third consecutive year Cryo-Save proposes a dividend increase,
indicating a strong belief in the future of the company and will allow its
shareholders to choose between a distribution in cash or in shares.

Further details will be provided when the Group publishes its results for the
year ended 31 December 2010 during the week commencing 21 March 2011.

Enquiries:

Cryo-Save Group + 31 (0) 575 548 998

Arnoud van Tulder, Chief Executive Officer



SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181

Kees Jongsma/Leon Melens




Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550

Christopher Theis



College Hill (UK) + 44 (0) 20 7457 2020

Rozi Morris/ Adrian Duffield



Free footage is available on www.videobankonline.com.

About Cryo-Save

With 150,000 samples saved, Cryo-Save is the leading stem cell bank in Europe
and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 40 countries on three
continents with state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (validation in progress).








click here for press release in PDF:
http://hugin.info/143308/R/1487396/422828.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:




(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE

[HUG#1487396]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET, study published in NEJM shows Nutreco CFO Cees van Rijn will retire on 30 September 2011
Bereitgestellt von Benutzer: hugin
Datum: 10.02.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 51300
Anzahl Zeichen: 2458

contact information:
Town:

Zutphen



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 328 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cryo-Save Group: Dividend proposal increase of 17%"
steht unter der journalistisch-redaktionellen Verantwortung von

Cryo-Save Group N.V. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cryo-Save Group N.V.



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z